Model
Edge
Alnylam Pharmaceuticals, Inc.
0001661908
Filing Type
4
Filing Date
5/18/2023
Updated
5/19/23, 10:06 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership